Ms. Jennifer E. Miller
Founders & President, Bioethics International
Jennifer E. Miller, PhD, is the Founder and President of Bioethics International, a NYC based nonprofit dedicated to transforming the way we understand and operationalize bioethics and patient-centricity in the healthcare innovation sector. She is also the Creator of the Good Pharma Scorecard, an index that ranks new medicines and pharmaceutical companies on their ethics and public health performance. Additionally, Dr. Miller is an Assistant Professor in NYU School of Medicine and was previously based at Duke University and Harvard University. She was recently appointed to the World Economic Forum, serving on the Global Futures Council.
A prolific writer, Dr. Miller has authored over 40 publications, including for Nature Medicine, Health Affairs, the Hastings Center Report, The Scientist, the Journal of Law, Medicine, and Ethics, The American Journal of Bioethics, Cambridge Quarterly of Healthcare Ethics, Pediatric Critical Care Medicine, The Journal of Pre-hospital and Disaster Medicine, and the Journal of the Society for Clinical Trials. She was a Fox News pundit from 2009 to 2012 and remains a commentator for print, radio and television news media, frequently featured on CBS news, Wall Street Journal, Washington Post, Bloomberg News, Forbes, and NPR.
Committed to public service, Dr. Miller serves on NYU’s Pharmacy and Therapeutics Committee, NYU’s Stem Cell Research Oversight Board, the J&J-NYU Compassionate-Use Advisory Committee (monitor) and the World Economic Forum. Previously, she served on the Center for Disease Control and Prevention’s (CDC) Task Force for Pediatric Emergency Mass Critical Care, the American Medical Association’s (AMA) Advanced Disaster Life Support Education Consortium, as a consultant to the United Nations Economic and Social Council, and on the PCORI-NIH Collaboratory.
Dr. Miller’s current work explores the ethics, transparency and governance of how medicines, biologics, and health technologies are researched, developed, marketed, priced, and made accessible to patients globally. She also specializes in the ethics of big data, the use of AI and data-sharing in healthcare innovation.